Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Leuk Lymphoma. 2015 Feb 20;56(9):2543–2551. doi: 10.3109/10428194.2014.1001986

Figure 1. Percent change in baseline palpable spleen length at week 12.

Figure 1

Waterfall plot demonstrating percent change in palpable spleen length for each subject at week 12 and colored coded by dose level. A negative percent change indicates a reduction in spleen length. Fifteen patients with baseline palpable splenomegaly were evaluable for this analysis at week 12 of lestaurtinib treatment.